Benevolent AI (XAMS:BAI) Preferred Dividends : €0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Benevolent AI's preferred dividends for the six months ended in Dec. 2023 was €0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Benevolent AI Preferred Dividends Historical Data

The historical data trend for Benevolent AI's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Preferred Dividends Chart

Benevolent AI Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Benevolent AI Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Preferred Dividends	Get a 7-Day Free Trial				-	-	-	-	-

Benevolent AI Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Benevolent AI (XAMS:BAI) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Benevolent AI Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (XAMS:BAI) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

2XA:Germany

Address

4-8 Maple Street, London, GBR, W1T 5HD

Website

https://www.benevolent.com

Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.